Technological Innovation for a Sustainable Future
Wantai BioPharm is committed to creating value that extends beyond financial success—we integrate environmental sustainability, social progress, and responsible governance into our core business strategy. By advancing green manufacturing, supporting equitable healthcare access, and upholding the highest compliance standards, we contribute China's scientific innovation and production excellence to the global fight for health security.
Governance Structure
Environmental Responsibility
Practice the concept of green development, build a resource-saving and environment-friendly enterprise, and promote low-carbon transformation and ecological protection.
Environmental Management System
- Fully launch the construction of the ISO 14001 environmental management system and the ISO 50001 energy management system, covering the whole process of research and development, production, and operation to ensure that environmental protection responsibilities are implemented in every link.
- Wantai BioPharm continuously improves its environmental management system through regular environmental audits and risk assessments, enhancing governance transparency and operational efficiency. By implementing real-time monitoring and corrective action tracking, we ensure full compliance while systematically preventing potential environmental risks.
Resource Recycling
- Wantai BioPharm has established a comprehensive solid waste classification management system, with particular emphasis on implementing full lifecycle digital tracking of hazardous waste. Our system enables complete traceability from generation to final disposal, ensuring strict compliance with environmental regulations and achieving 100% harmless treatment of all hazardous materials.
- Wantai BioPharm actively implements green packaging design initiatives to enhance environmental sustainability across our product lines. Through comprehensive packaging optimization strategies including the elimination of secondary packaging, structural redesign, and eco-friendly material substitution, we have achieved a 30% reduction in packaging material consumption while maintaining product integrity.
Addressing Climate Change
- Carry out the identification and management of climate change risks, strengthen the response to environmental risks, and enhance the resilience of the company's operations.
- Actively promote energy conservation and emission reduction projects, optimize production equipment and technological processes, and reduce energy consumption and carbon emissions.
Key Performance
1
National-level Green Factory
¥4,238,900
Total investment in environmental protection
62,849.82t
Total greenhouse gas emissions in Scope 1 and Scope 2
2,175.96t
Greenhouse gas emissions reduced by emission reduction measures
Social Responsibility
Safeguard health through technological innovation, give back to society through public welfare actions, and create a warm and sustainable development ecosystem.
Medical Inclusive Action
- Wantai BioPharm has partnered with the China Primary Health Care Foundation and China Women's Development Foundation to provide free Chinese bivalent HPV vaccinations, supporting cervical cancer elimination efforts and improving public health. Through this initiative, we are expanding vaccine access to underserved populations while raising disease prevention awareness, contributing to the global fight against cervical cancer.
- Actively participate in global health assistance, provide Hepatitis E vaccine and technical support to developing countries such as South Sudan, and demonstrate the humanitarian responsibility of Chinese enterprises.
Employee Care
- Build a diversified training system, covering professional skills training, career development courses, and soft skills improvement to meet the needs of employees at different levels and positions.
- Provide employees with a safe and healthy working environment, regularly carry out occupational health examinations and safety training to protect employees' rights and interests.
- Pay attention to employees' spiritual and cultural needs, build staff libraries, hold cultural activities, create a positive corporate culture atmosphere, and enhance team cohesion.
Quality and Supply Chain
- Establish a complete quality management system, strictly implement ISO 13485 and GMP specifications to ensure that every link of the product from research and development to production meets the highest safety standards.
- Promote the sustainable development of the supply chain, jointly formulate ESG goals with suppliers, conduct regular evaluations and training, and enhance the overall sense of responsibility of the supply chain.
Key Performance
The cumulative export of the bivalent HPV vaccine 'Cecolin®' has exceeded 8 million doses, providing HPV immunoprotection for more than 6 million people.
The cumulative export of the Hepatitis E vaccine 'Hecolin®' has exceeded 149,000 doses, providing Hepatitis E immunoprotection for 70,000 people.
Average training duration per employee: 70.81 hours.
100% of the product production bases have obtained ISO 9001/ISO 13485/GMP certifications.
Corporate Governance
Drive long-term value through transparent governance and lay a solid foundation for development with a compliance culture.
Governance System
- Wantai BioPharm has established a modern corporate governance structure that clearly defines the respective roles and responsibilities of the Board of Directors, Board of Supervisors, and Executive Management. This framework ensures scientific decision-making and operational transparency through specialized board committees, rigorous compliance protocols, and stakeholder-aligned policies, while maintaining independent oversight and strategic guidance for sustainable development.
- Regularly release special ESG reports, disclose the company's practices and progress in the aspects of environment, society, and governance, and accept social supervision.
Risk Management and Control
- Improve the internal control system, covering key areas such as finance, operation, and compliance to ensure the standardized and orderly operation of the company.
- Combine internal audit with external evaluation to continuously optimize the risk management mechanism and enhance the company's risk resistance ability.
Responsible Operation
- Strengthen the business ethics training for all employees, advocate the concept of honest operation, and ensure that employees' behaviors comply with laws, regulations, and the company's values.
- Establish a reporting and feedback mechanism, encourage employees and partners to jointly supervise, and maintain a fair and transparent business environment.
- Formulate the 'Responsible Marketing Policy' and actively implement the marketing system training to ensure that all marketing activities are compliant and effective.
Key Performance
33%
Proportion of female senior executives
0
Number of major compliance incidents
98.1%
Coverage rate of business ethics training
100%
Timely rate of information disclosure
90%
Coverage rate of responsible marketing training
ESGESG
Filing Number:(京)网药械信息备字（2025）第 00190 号
|
Copyright©Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
|
|
京公网安备11011402010353号 
Alibaba Cloud provides cloud computing and security services.|
It supports
|
Powered by CloudDream
|
Terms Of Use|
Privacy Statement